m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer
about
Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity.Preoperative clinical radioimmunodetection of pancreatic cancer by 111 In-labeled chimeric monoclonal antibody Nd2.Antibody-dependent cytotoxicity mediated by chimeric monoclonal antibody Nd2 and experimental immunotherapy for pancreatic cancer.
P2860
m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
m17-1A-, c17-1A- and cSF25-med ...... patients with advanced cancer
@ast
m17-1A-, c17-1A- and cSF25-med ...... patients with advanced cancer
@en
type
label
m17-1A-, c17-1A- and cSF25-med ...... patients with advanced cancer
@ast
m17-1A-, c17-1A- and cSF25-med ...... patients with advanced cancer
@en
prefLabel
m17-1A-, c17-1A- and cSF25-med ...... patients with advanced cancer
@ast
m17-1A-, c17-1A- and cSF25-med ...... patients with advanced cancer
@en
P2093
P2860
P356
P1476
m17-1A-, c17-1A- and cSF25-med ...... patients with advanced cancer
@en
P2093
Guillou PJ
Pullyblank AM
P2860
P2888
P304
P356
10.1038/BJC.1994.390
P407
P577
1994-10-01T00:00:00Z